10x Genomics Q3 2026 Results: Net Loss of $19.4M, Loss Narrows
10x Genomics, Inc. reported its third quarter 2026 results, highlighting continued revenue growth driven by its spatial biology and single-cell analysis platforms. The company maintained its full-year revenue guidance while noting improvements in gross margins due to manufacturing efficiencies.
- Key figure
- Net loss $19.4M